Form 8-K - Current report:
SEC Accession No. 0001144204-19-033391
Filing Date
2019-07-01
Accepted
2019-07-01 16:23:37
Documents
3
Period of Report
2019-06-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv524622_8k.htm 8-K 26195
2 EXHIBIT 99.1 tv524622_ex99-1.htm EX-99.1 17981
3 GRAPHIC image_001.jpg GRAPHIC 4340
  Complete submission text file 0001144204-19-033391.txt   51435
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 19933485
SIC: 2836 Biological Products, (No Diagnostic Substances)